Tumor marker screens, namely, prostate-specific antigen (PSA), carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA 19-9), alpha-fetoprotein (AFP), and beta-human chorionic gonadotrophin (B-HCG), were however negative. Here, CEACAM5 is linked to neoplasm.